GlassScriptPhysician profile
Sean Mendez
NPI 1609366962
$2,326.86
in general payments reported to CMS, 2019-2025
13 companies · $414 in 2025
The $414 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $430 · 2022: $581 · 2023: $674 · 2024: $228 · 2025: $414.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,316.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,316.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,269.69 | 2021-2024 | Farxiga, Lokelma, Andexxa |
| Amgen INC. | $345.56 | 2022-2024 | Repatha |
| Abbott Laboratories | $161.45 | 2025 | Triclip, Aveir |
| Boston Scientific Corporation | $155.00 | 2025 | Farapulse |
| Kestra Medical Technology Services, INC. | $151.46 | 2024-2025 | Assure Wcd |
| Biotronik INC. | $54.56 | 2021 | |
| Kiniksa Pharmaceuticals, LTD. | $33.41 | 2023 | Arcalyst |
| Lantheus Medical Imaging, INC. | $32.57 | 2022 | |
| Irhythm Technologies, INC. | $29.91 | 2024 | Zio Monitor, Zio Xt Patch |
| Novartis Pharmaceuticals Corporation | $25.67 | 2024 | |
| Janssen Pharmaceuticals, INC | $25.55 | 2024 | Xarelto |
| Philips North America LLC | $21.05 | 2022 | |
| Abiomed | $20.98 | 2024 | Impella |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Mendez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.